美国内科医师学会最佳实践第168号。肥胖的调查与管理。
acp Best Practice No 168. The investigation and management of obesity.
作者信息
Labib M
机构信息
Department of Clinical Biochemistry, Russells Hall Hospital, Dudley, West Midlands DY1 2HQ, UK.
出版信息
J Clin Pathol. 2003 Jan;56(1):17-25. doi: 10.1136/jcp.56.1.17.
Abstract
Obesity is a chronic condition characterised by an excess of body fat. It is a complex disorder of appetite regulation and energy metabolism controlled by specific biological factors. In the past 10 years, great progress has been made in the scientific understanding of the pathophysiology of obesity and the interactions between genetic predisposition to weight gain and the environment. This article will review the current understanding of the pathophysiology and the approach to the investigation and management of obesity.
摘要
肥胖是一种以体内脂肪过多为特征的慢性疾病。它是一种由特定生物因素控制的食欲调节和能量代谢的复杂紊乱。在过去十年中，在对肥胖病理生理学以及体重增加的遗传易感性与环境之间相互作用的科学认识方面取得了巨大进展。本文将综述目前对肥胖病理生理学的认识以及肥胖的调查和管理方法。
相似文献
1
acp Best Practice No 168. The investigation and management of obesity.美国内科医师学会最佳实践第168号。肥胖的调查与管理。
J Clin Pathol. 2003 Jan;56(1):17-25. doi: 10.1136/jcp.56.1.17.
2
What fuels fat.什么为脂肪提供能量。
Sci Am. 2007 Sep;297(3):72-81. doi: 10.1038/scientificamerican0907-72.
3
Treatment of obesity: should we target the individual or society?
Curr Pharm Des. 2003;9(15):1151-63. doi: 10.2174/1381612033454946.
4
Obesity in neurobiology.神经生物学中的肥胖
Prog Neurobiol. 2008 Jan;84(1):85-103. doi: 10.1016/j.pneurobio.2007.09.003. Epub 2007 Oct 4.
5
Obesity - an epidemic of the twenty-first century: an update for psychiatrists.肥胖——21世纪的流行病：给精神科医生的最新资讯
J Psychopharmacol. 2005 Nov;19(6 Suppl):6-15. doi: 10.1177/0269881105058377.
6
Medical management of obesity.肥胖的医学管理。
Am Fam Physician. 2000 Jul 15;62(2):419-26.
7
Obesity: Scope, Lifestyle Interventions, and Medical Management.肥胖症：范围、生活方式干预及医学管理
Tech Vasc Interv Radiol. 2020 Mar;23(1):100653. doi: 10.1016/j.tvir.2020.100653. Epub 2020 Jan 11.
8
Leptin and the regulation of body weigh.瘦素与体重调节
Keio J Med. 2011;60(1):1-9. doi: 10.2302/kjm.60.1.
9
Review of physiology, clinical manifestations, and management of hypothalamic obesity in humans.人类下丘脑性肥胖的生理学、临床表现及管理综述
Pituitary. 2009;12(2):87-95. doi: 10.1007/s11102-008-0096-4.
10
Why I Treat Obesity.我为何治疗肥胖症。
Perm J. 2019;23. doi: 10.7812/TPP/18-240. Epub 2019 May 15.
引用本文的文献
1
Assessment of the Body Composition and Bone Calcification of Students of Police Schools and Police Training Centers in Poland-A Cross-Sectional Study.波兰警校和警察培训中心学生的身体成分和骨钙化评估——一项横断面研究。
Int J Environ Res Public Health. 2022 Jun 10;19(12):7161. doi: 10.3390/ijerph19127161.
2
Effect of soybean milk fermented with HFY01 isolated from yak yogurt on weight loss and lipid reduction in mice with obesity induced by a high-fat diet.从牦牛酸奶中分离出的HFY01发酵豆浆对高脂饮食诱导的肥胖小鼠体重减轻和脂质降低的影响。
RSC Adv. 2020 Sep 15;10(56):34276-34289. doi: 10.1039/d0ra06977a. eCollection 2020 Sep 10.
3
Sex- and Gender-Based Pharmacological Response to Drugs.药物的基于性别的药理学反应
Pharmacol Rev. 2021 Apr;73(2):730-762. doi: 10.1124/pharmrev.120.000206.
4
Acetylshikonin from Zicao Prevents Obesity in Rats on a High-Fat Diet by Inhibiting Lipid Accumulation and Inducing Lipolysis.紫草根中的乙酰紫草素通过抑制脂质积累和诱导脂肪分解来预防高脂饮食大鼠肥胖。
PLoS One. 2016 Jan 15;11(1):e0146884. doi: 10.1371/journal.pone.0146884. eCollection 2016.
5
Childhood Obesity: Review of a growing Problem.儿童肥胖：对一个日益严重问题的综述
Int J Clin Pediatr Dent. 2012 Sep;5(3):237-41. doi: 10.5005/jp-journals-10005-1175. Epub 2012 Dec 5.
6
Profiling of chicken adipose tissue gene expression by genome array.利用基因组芯片分析鸡脂肪组织基因表达情况。
BMC Genomics. 2007 Jun 27;8:193. doi: 10.1186/1471-2164-8-193.
7
Physiological and metabolic functions of melatonin.褪黑素的生理和代谢功能。
J Physiol Biochem. 2004 Mar;60(1):61-72. doi: 10.1007/BF03168221.
本文引用的文献
1
Genetic and environmental contributions to the variance of the body mass index in a Norwegian sample of first- and second-degree relatives.在挪威一级和二级亲属样本中，遗传因素和环境因素对体重指数方差的影响。
Am J Hum Biol. 1991;3(3):257-267. doi: 10.1002/ajhb.1310030305.
2
Food fails to suppress ghrelin levels in obese humans.食物无法抑制肥胖人群体内的胃饥饿素水平。
J Clin Endocrinol Metab. 2002 Jun;87(6):2984. doi: 10.1210/jcem.87.6.8738.
3
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin.通过生活方式干预或二甲双胍降低2型糖尿病的发病率。
N Engl J Med. 2002 Feb 7;346(6):393-403. doi: 10.1056/NEJMoa012512.
4
Ghrelin enhances appetite and increases food intake in humans.胃饥饿素可增强人类的食欲并增加食物摄入量。
J Clin Endocrinol Metab. 2001 Dec;86(12):5992. doi: 10.1210/jcem.86.12.8111.
5
Stomach is a major source of circulating ghrelin, and feeding state determines plasma ghrelin-like immunoreactivity levels in humans.胃是循环中胃饥饿素的主要来源，进食状态决定了人类血浆中胃饥饿素样免疫反应水平。
J Clin Endocrinol Metab. 2001 Oct;86(10):4753-8. doi: 10.1210/jcem.86.10.7885.
6
The Swedish Obese Subjects (SOS) study--rationale and results.瑞典肥胖受试者（SOS）研究——原理与结果。
Int J Obes Relat Metab Disord. 2001 May;25 Suppl 1:S2-4. doi: 10.1038/sj.ijo.0801687.
7
Randomized placebo-controlled trial of long-term treatment with sibutramine in mild to moderate obesity.西布曲明长期治疗轻至中度肥胖的随机安慰剂对照试验。
J Fam Pract. 2001 Jun;50(6):505-12.
8
Increasing prevalence of obesity in primary school children: cohort study.小学生肥胖患病率上升：队列研究。
BMJ. 2001 May 5;322(7294):1094-5. doi: 10.1136/bmj.322.7294.1094.
9
Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance.糖耐量受损人群通过生活方式改变预防2型糖尿病
N Engl J Med. 2001 May 3;344(18):1343-50. doi: 10.1056/NEJM200105033441801.
10
Obesity: preventing and managing the global epidemic. Report of a WHO consultation.肥胖：预防和管理全球流行疾病。世界卫生组织磋商报告。
World Health Organ Tech Rep Ser. 2000;894:i-xii, 1-253.
Zotero 插件